Everest Group Report Underscores Need for Scientific Expertise in Life Sciences IT
Event summary
- Everest Group released a report on March 19, 2026, emphasizing the need for scientific expertise in life sciences IT service delivery.
- The report highlights that digital transformation in biopharma requires scientific accuracy from the outset.
- Zifo Technologies leverages this report to advocate for science-first IT delivery models.
- Key areas benefiting from embedded scientific expertise include drug discovery (77%), clinical development (73%), and manufacturing operations (37%).
- Nearly 80% of pharma leaders view scientific expertise as a major deciding factor in IT partnerships.
The big picture
The Everest Group report highlights a critical gap in the life sciences industry: the disconnect between rapid scientific advancements and the lagging informatics systems supporting them. As AI and digital transformation become more prevalent, the need for scientific expertise in IT delivery is becoming a key differentiator. Zifo Technologies positions itself as a solution provider, emphasizing the importance of integrating scientific knowledge into technology platforms to drive business value and mitigate risks.
What we're watching
- Adoption Pace
- How quickly biopharma companies will adopt science-first IT models and whether this adoption will lead to measurable improvements in efficiency and compliance.
- Competitive Differentiation
- Whether Zifo Technologies can leverage this report to position itself as a leader in science-driven IT solutions, differentiating from generic tech providers.
- Regulatory Compliance
- The impact of embedded scientific expertise on reducing compliance risks and ensuring regulatory adherence in highly regulated industries.